Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT03836846
Other study ID # 029021
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date October 1, 2019
Est. completion date October 31, 2021

Study information

Verified date January 2022
Source Kaiser Permanente
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

We will investigate the association between social media use and depression in adolescents admitted to a psychiatric unit and continue to follow their progress after discharge in outpatient clinic services. We expect improvement in their depressive symptoms by modifying social media use and adding a mental health app to further encourage the positive effects of social media.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date October 31, 2021
Est. primary completion date October 31, 2020
Accepts healthy volunteers No
Gender All
Age group 13 Years to 17 Years
Eligibility Inclusion Criteria: - Participants admitted to inpatient psychiatric unit - Kaiser insured participants between 13-17 years of age with parental consent - positive for social media use - English speaking Exclusion Criteria: - pregnant - non English speaking

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
CBT Mobile App
TAU and the additional treatment of a Mental Health App (What's Up?). This app will be used to guide adolescents through cognitive behavioral therapy and acceptance commitment therapy techniques, as well as to assist in developing coping mechanisms to prevent readmission.
Treatment as usual
TAU as per standard of care

Locations

Country Name City State
United States Canyon Ridge Hospital Chino California

Sponsors (1)

Lead Sponsor Collaborator
Kaiser Permanente

Country where clinical trial is conducted

United States, 

References & Publications (3)

Baños RM, Etchemendy E, Mira A, Riva G, Gaggioli A, Botella C. Online Positive Interventions to Promote Well-being and Resilience in the Adolescent Population: A Narrative Review. Front Psychiatry. 2017 Jan 30;8:10. doi: 10.3389/fpsyt.2017.00010. eCollection 2017. — View Citation

Luxton DD, June JD, Fairall JM. Social media and suicide: a public health perspective. Am J Public Health. 2012 May;102 Suppl 2:S195-200. doi: 10.2105/AJPH.2011.300608. Epub 2012 Mar 8. — View Citation

Pantic I. Online social networking and mental health. Cyberpsychol Behav Soc Netw. 2014 Oct;17(10):652-7. doi: 10.1089/cyber.2014.0070. Epub 2014 Sep 5. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Comparing depression scale,PHQ9-A (Patient Health Questionnaire, Adolescent Version), with social media use Compare presence and severity of depressive symptoms in treatment as usual (TAU) group with TAU and the mobile app intervention group. The presence and severity of depression will be determined using the PHQ9-A (Patient Health Questionnaire, adolescent version), a 9-question depression scale that is based on the DSM-IV diagnostic criteria of depression and modified for teens to further inquire about other aspects of depression such as dysthymia, suicide risk, and other mental illnesses. The PHQ-9A scores each of the DSM-IV criteria as "0" (not at all) to "3" (nearly every day). Total depression severity score ranges of 0-4 none, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe. 1 month
Primary Comparing depression scale,PHQ9-A (Patient Health Questionnaire, Adolescent Version), with social media use Compare presence and severity of depressive symptoms in treatment as usual (TAU) group with TAU and the mobile app intervention group. The presence and severity of depression will be determined using the PHQ9-A (Patient Health Questionnaire, adolescent version), a 9-question depression scale that is based on the DSM-IV diagnostic criteria of depression and modified for teens to further inquire about other aspects of depression such as dysthymia, suicide risk, and other mental illnesses. The PHQ-9A scores each of the DSM-IV criteria as "0" (not at all) to "3" (nearly every day). Total depression severity score ranges of 0-4 none, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe. 3 months
Primary Comparing depression scale,PHQ9-A (Patient Health Questionnaire, Adolescent Version), with social media use Compare presence and severity of depressive symptoms in treatment as usual (TAU) group with TAU and the mobile app intervention group. The presence and severity of depression will be determined using the PHQ9-A (Patient Health Questionnaire, adolescent version), a 9-question depression scale that is based on the DSM-IV diagnostic criteria of depression and modified for teens to further inquire about other aspects of depression such as dysthymia, suicide risk, and other mental illnesses. The PHQ-9A scores each of the DSM-IV criteria as "0" (not at all) to "3" (nearly every day). Total depression severity score ranges of 0-4 none, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe. 6 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A